Artelo Biosciences Inc.

NASDAQ: ARTLW · Real-Time Price · USD
0.01
0.00 (78.57%)
At close: Jun 17, 2024, 10:00 PM

Artelo Biosciences Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Aug 31, 2021
Revenue
n/a n/a
Cost of Revenue
n/a n/a
Gross Profit
n/a n/a
Operating Income
-10.29M -7.44M
Interest Income
2K 2K
Pretax Income
-10.08M -7.44M
Net Income
-9.87M -7.44M
Selling & General & Admin
5.96M 4.6M
Research & Development
4.32M 2.84M
Other Expenses
n/a n/a
Operating Expenses
10.29M 7.44M
Interest Expense
5K n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
10.29M 7.44M
Income Tax Expense
-209K -4K
Shares Outstanding (Basic)
2.83M 1.25M
Shares Outstanding (Diluted)
2.83M 1.25M
EPS (Basic)
-3.49 -5.97
EPS (Diluted)
-3.49 -5.97
EBITDA
-10.29M -7.44M
EBIT
n/a n/a
Depreciation & Amortization
2K -2K